Christopher Clark

Christopher Clark, a highly sought after consultant for biotechnology startups, accepted the role of Chief Financial Officer at Neovasc Inc., and was instrumental in the initial and ongoing development of Neovasc as a publicly traded company. Mr. Clark has almost 20 years’ finance and accounting experience in public practice, and in public and private companies, most recently focused in the medical device sector. Previous experience includes financial leadership roles with large automotive and telecom firms, in which he developed deep expertise in the development and management of sophisticated financial systems. He received his designation as a chartered accountant from the Institute of Chartered Accountants of England and Wales, and articled with KPMG before moving to Canada from England in 1998. He has an honors degree in economics from Swansea University and a post-graduate diploma from Keble College, Oxford.